[HTML][HTML] Application of prostate cancer models for preclinical study: advantages and limitations of cell lines, patient-derived xenografts, and three-dimensional culture …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - mdpi.com
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
[PDF][PDF] Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - pdfs.semanticscholar.org
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - 2019 - agris.fao.org
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue… - Cells (2073-4409 …, 2019 - search.ebscohost.com
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - cir.nii.ac.jp
抄録< jats: p> Various preclinical models have been developed to clarify the
pathophysiology of prostate cancer (PCa). Traditional PCa cell lines from clinical metastatic …
pathophysiology of prostate cancer (PCa). Traditional PCa cell lines from clinical metastatic …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - search.proquest.com
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - pubmed.ncbi.nlm.nih.gov
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
[HTML][HTML] Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - ncbi.nlm.nih.gov
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of …
T Namekawa, K Ikeda, K Horie-Inoue, S Inoue - Cells, 2019 - europepmc.org
Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …
cancer (PCa). Traditional PCa cell lines from clinical metastatic lesions, as exemplified by …